RNAi screening identifies KAT8 as a key molecule important for cancer cell survival

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 5, 2013, Pages 870-877

  Zhang, Shuang ^a,b   Liu, Xianhong ^b   Zhang, Yong ^a   Cheng, Ying ^b   Li, Yang ^a  

^a Basic Medical College   (China)

^b JILIN PROVINCIAL CANCER HOSPITAL   (China)

Author keywords

cell survival; cyclin D1; HATs; KAT8; p53; RNAi screen

Indexed keywords

HISTONE ACETYLTRANSFERASE; KAT8 PROTEIN, HUMAN; SMALL INTERFERING RNA;

CELL CYCLE CHECKPOINT; CELL SURVIVAL; ENZYMOLOGY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HISTONE ACETYLTRANSFERASES; HUMANS; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84882997808     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Marmorstein R. Structure of histone acetyltransferases. J Mol Biol 2001; 311: 433-444.
2. Minucci S and Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6: 38-51.
3. Roth SY, Denu JM and Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001; 70: 81-120.
4. Bolden JE, Peart MJ and Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5: 769-784.
5. Eliseeva ED, Valkov V, Jung M and Jung MO. Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 2007; 6: 2391-2398.
6. Patani N, Jiang WG, Newbold RF and Mokbel K. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer. Anticancer Res 2011; 31: 4115-4125.
7. Panagopoulos I, Fioretos T, Isaksson M, Samuelsson U, Billstrom R, Strombeck B, Mitelman F and Johansson B. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet 2001; 10: 395-404.
8. Aguiar RC, Chase A, Coulthard S, Macdonald DH, Carapeti M, Reiter A, Sohal J, Lennard A, Goldman JM and Cross NC. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood 1997; 90: 3130-3135.
9. Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T and Caldas C. Mutations truncating the EP300 acetylase in human cancers. Nat Genet 2000; 24: 300-303.
10. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T and Miyaki M. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 1996; 12: 1565-1569.
11. Iorns E, Lord CJ, Turner N and Ashworth A. Utilizing RNA interference to enhance cancer drug discovery. Nat Rev Drug Discov 2007; 6: 556-568.
12. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J and Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000; 102: 463-473.
13. He H, Yu FX, Sun C and Luo Y. CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. PLoS One 2011; 6: e22088.
14. Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L, Martinato F, Sardella D, Verrecchia A, Bennett S, Confalonieri S, Cesaroni M, Marchesi F, Gasco M, Scanziani E, Capra M, Mai S, Nuciforo P, Crook T, Lough J and Amati B. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 2007; 448: 1063-1067.
15. Lavoie JN, L'Allemain G, Brunet A, Muller R and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996; 271: 20608-20616.
16. Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WF, Victor TC, Anderson LM and Gelderblom WC. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSk 877 3beta activity. Carcinogenesis 2000; 21: 1537-1546.
17. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS and McMahon SB. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24: 841-851.
18. Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C, Thuerigen O, Sinn HP, Akhtar A and Lichter P. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer 2008; 122: 1207- 1213.
19. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
20. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E and Fornace AJ Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999; 18: 6845-6854.
21. Thompson T, Tovar C, Yang H, Carvajal D, Vu BT, Xu Q, Wahl GM, Heimbrook DC and Vassilev LT. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem 2004; 279: 53015- 53022.
22. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849-862.
23. Tang Y, Luo J, Zhang W and Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2006; 24: 827-839.
24. Tyteca S, Legube G and Trouche D. To die or not to die: a HAT trick. Mol Cell 2006; 24: 807- 808.
25. Miyashita T and Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-299.
26. Di Cerbo V and Schneider R. Cancers with wrong HATs: the impact of acetylation. Brief Funct Genomics 2013; [Epub ahead of print].
27. Micci F, Panagopoulos I, Bjerkehagen B and Heim S. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 2006; 66:107-112
28. Luedeke M, Linnert CM, Hofer MD, Surowy HM, Rinckleb AE, Hoegel J, Kuefer R, Rubin MA, Vogel W and Maier C. Predisposition for TMPRSS2- ERG fusion in prostate cancer by variants in DNA repair genes. Cancer Epidemiol Biomarkers Prev 2009; 18: 3030-3035.